Literature DB >> 31154

[On the toxicology of carbromal. IV. Binding of carbromal and its hypnotically active metabolites to human plasma proteins (author's transl)].

H W Vohland, B Streichert.   

Abstract

The binding of carbromal and its metabolites bromoethylbutyramide and ethylbutyrylurea to human plasma proteins was investigated in vitro by use of Sephadex-gelfiltration, equilibrium dialysis and ultrafiltration. No differences appeared in the binding characteristics of human plasma and of human albumine. In a concentration range between 3.10-8 and 1.5.10-6 moles/ml about 40% of the carbromal, and in a concentration range between 3.10-8 and 1.10-5 moles/ml about 30% of the bromoethylbutyramide are bound to plasma proteins. Proteinbinding of ethylbutyrylurea was found to be less than 5%. The binding constants, Ka, to human albumine and the binding energies deltaF 0 were found to be in the range of 0.5--1.2.10(3) L/Mol and 1.7--4.4 kcal/Mol, respectively. Protein binding of carbromal, bromoethylbutyramide, their chlorinated analgous compounds, chloroethylbutyrylurea and chloroethylbutyramide, and of ethylbutyrylurea is strongly correlated to the partition coefficients of these compounds between n-octanol and water, indicating that the intensity of proteinbinding depends on the hydrophobic character of the substances tested.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 31154     DOI: 10.1007/bf00351771

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  16 in total

1.  [On the toxicology of carbromal. I. Estimation of carbromal and its hypnotically active metabolites in rats and humans (author's transl)].

Authors:  H W Vohland; S Hadisoemarto; B Wanke
Journal:  Arch Toxicol       Date:  1976-09-15       Impact factor: 5.153

2.  [THE BINDING OF SULFONAMIDES TO PROTEIN BODIES. 4. CONCENTRATION AND TEMPERATURE DEPENDENCE IN PROTEIN BINDING].

Authors:  W SCHOLTAN
Journal:  Arzneimittelforschung       Date:  1964-10

3.  [Extracorporeal dialysis of luminal].

Authors:  M KESSEL; K IBE; G NEUHAUS; H REMMER; H WELLER
Journal:  Klin Wochenschr       Date:  1962-06-01

4.  [On the toxicology of carbromal. II. Pharmacokinetics of carbromal and its hypnotically active metabolites in the rat (author's transl)].

Authors:  H W Vohland; S Hadisoemarto; B Wanke
Journal:  Arch Toxicol       Date:  1977-08-09       Impact factor: 5.153

5.  [Methods of determination, physico-chemical properties and pharmacokinetic signifance of plasma protein binding of drugs].

Authors:  J Krieglstein
Journal:  Arzneimittelforschung       Date:  1973-11

6.  [Quantitative determination of protein binding of drugs by gel filtration].

Authors:  J Krieglstein; G Kuschinsky
Journal:  Arzneimittelforschung       Date:  1968-03

7.  [The clinical course of severe carbromal poisoning (author's transl)].

Authors:  G Grosse; W Höfer; H Gruska; K H Beyer; S Kubicki; T Schirop
Journal:  Klin Wochenschr       Date:  1974-01-01

8.  Comparison of the bromureide sedative-hypnotic drugs, bromvaletone (bromisoval) and carbromal, and their chloro analogues in mice.

Authors:  R I Mrongovius; G A Gaff; M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1976 Sep-Oct       Impact factor: 2.557

9.  A study in mice of bromo and chloro acylurea analogues of the sedative-hypnotic bromureides.

Authors:  R I Mrongovius; M J Rand
Journal:  Clin Exp Pharmacol Physiol       Date:  1977 Jan-Feb       Impact factor: 2.557

Review 10.  [The influence of plasma protein binding on distribution and pharmacological activity of tranquilizers of the benzodiazepine group (author's transl)].

Authors:  W E Müller
Journal:  Klin Wochenschr       Date:  1977-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.